KRNMF Stock Chart & Stats
$4.63
-$0.06(-1.28%)
―
--
Day’s Range― - ―
52-Week Range$3.96 - $5.27
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$1.65B
Enterprise Value$8.69K
Total Cash (Recent Filing)$1.42B
Total Debt (Recent Filing)$8.35B
Price to Earnings (P/E)99.5
Beta0.03
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-8.51
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio2.42
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.47
Revenue Forecast (FY)$6.26B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained revenue expansion indicates growing demand across Clariane’s care services. Exposure to recurring residential, clinical, and home-care activity can support continued top-line growth as healthcare needs rise.
Stable Operating MarginsRelatively stable operating margins suggest the core care model can convert growing revenue into recurring operating earnings. This resilience is important in a labor-intensive, regulated sector exposed to wage and reimbursement pressure.
Consistent Free Cash FlowConsistently positive operating and free cash flow provides internal funding for care facilities, maintenance, and operational needs. It also gives management a durable source of liquidity, although debt service absorbs part of this capacity.
Bears Say
Elevated And Rising LeverageHigher leverage increases Clariane’s sensitivity to refinancing costs, interest rates, and operating volatility. It can restrict investment flexibility and leave less cash available for expansion or unexpected regulatory and staffing pressures.
Weak Net ProfitabilityWeak bottom-line earnings show that financing and other costs are absorbing much of the operating profit. This limits retained capital generation and reduces resilience if reimbursement, labor, or occupancy conditions deteriorate.
Moderate Debt CoverageAlthough cash generation is positive, its coverage of total debt remains moderate rather than strong. This implies that meaningful deleveraging could take time and that balance-sheet repair may compete with ongoing capital and care-service requirements.
Clariane News
KRNMF FAQ
What was Clariane’s price range in the past 12 months?
Clariane lowest stock price was $3.96 and its highest was $5.27 in the past 12 months.
What is Clariane’s market cap?
Clariane’s market cap is $1.65B.
When is Clariane’s upcoming earnings report date?
Clariane’s upcoming earnings report date is Mar 04, 2027 which is in 178 days.
How were Clariane’s earnings last quarter?
Clariane released its earnings results on Jul 29, 2026. The company reported -$0.154 earnings per share for the quarter.
Is Clariane overvalued?
According to Wall Street analysts Clariane’s price is currently Undervalued.
Does Clariane pay dividends?
Clariane does not currently pay dividends.
What is Clariane’s EPS estimate?
Clariane’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clariane have?
Currently, no data Available
What happened to Clariane’s price movement after its last earnings report?
Clariane reported an EPS of -$0.154 in its last earnings report. Following the earnings report the stock price went up 2.544%.
Which hedge fund is a major shareholder of Clariane?
Currently, no hedge funds are holding shares in KRNMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Clariane
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Technical Analysis
Ownership Overview
―
Insiders
2.95% Mutual Funds
― Other Institutional Investors
93.19% Public Companies and
Individual Investors